Granted
The Board granted an initial evaluation of 30 percent for herpes anogenital infection, as the Veteran required systemic therapy for a total duration of 6 weeks or more over the past year.
The deciding factor: The Veteran's condition required systemic therapy (Acyclovir) for a total duration of 6 weeks or more, but not constant, over the past 12-month period, which met the criteria for a 30 percent rating under DC 7820.
- Claimed conditions
- herpes anogenital infection
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 30%
- Decision date
- October 23, 2025
- Citation
- A25092082
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.